At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NTRB Nutriband Inc.
Trading 01-09 13:27:06 EST
4.47
+0.05
+1.13%
High4.54Low4.40Vol11.80K
Open4.48D1 Closing4.42Amplitude3.17%
Mkt Cap54.42MTradable Cap17.41MTotal Shares12.17M
T/O52.37KT/O Rate0.30%Tradable Shares3.90M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Nutriband Inc. joins Russell Microcap and Russell 3000E Indexes
Reuters  ·  2025-12-31
Nutriband Inc. joins Russell Microcap and Russell 3000E Indexes
Nutriband CEO Publishes Letter to Shareholders
GlobeNewswire  ·  2025-12-31
Nutriband CEO Publishes Letter to Shareholders
Nutriband (NASDAQ:NTRB) shareholders are up 27% this past week, but still in the red over the last five years
Simply Wall St.  ·  2025-12-30
Nutriband (NASDAQ:NTRB) shareholders are up 27% this past week, but still in the red over the last five years
Nutriband Sells 90% Stake in Pocono Pharmaceutical to EarthVision Bio for $5 Million
Reuters  ·  2025-12-29
Nutriband Sells 90% Stake in Pocono Pharmaceutical to EarthVision Bio for $5 Million
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to Earthvision Bio
THOMSON REUTERS  ·  2025-12-29
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to Earthvision Bio
Nutriband Inc - Proceeds to Fund Development of Aversa Fentanyl Patch
THOMSON REUTERS  ·  2025-12-29
Nutriband Inc - Proceeds to Fund Development of Aversa Fentanyl Patch
Nutriband Inc - Shareholders to Retain 10% Stake in Earth Vision Bio
THOMSON REUTERS  ·  2025-12-29
Nutriband Inc - Shareholders to Retain 10% Stake in Earth Vision Bio
Nutriband Inc. Announces Date for Upcoming Annual Meeting of Stockholders
Reuters  ·  2025-12-20
Nutriband Inc. Announces Date for Upcoming Annual Meeting of Stockholders
BRIEF-Nutriband Signs Letter Of Intent With Qvanta Group Of Companies
Reuters  ·  2025-12-18
BRIEF-Nutriband Signs Letter Of Intent With Qvanta Group Of Companies
Nutriband Signs LOI to Explore Quantum-AI Collaboration with Qvanta Group
Reuters  ·  2025-12-18
Nutriband Signs LOI to Explore Quantum-AI Collaboration with Qvanta Group
Nutriband Inc. Signs Letter of Intent With Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
THOMSON REUTERS  ·  2025-12-18
Nutriband Inc. Signs Letter of Intent With Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
Nutriband Partners with Kindeva to Develop Abuse-Deterrent Fentanyl Patch
Reuters  ·  2025-12-18
Nutriband Partners with Kindeva to Develop Abuse-Deterrent Fentanyl Patch
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
GlobeNewswire  ·  2025-12-18
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
Nutriband Inc. to Present at Noble Capital Markets Emerging Growth Equity Conference
Reuters  ·  2025-11-24
Nutriband Inc. to Present at Noble Capital Markets Emerging Growth Equity Conference
Nutriband Inc - Meets With FDA for Aversa Fentanyl Feedback
THOMSON REUTERS  ·  2025-10-28
Nutriband Inc - Meets With FDA for Aversa Fentanyl Feedback
Nutriband announces meeting completed with U.S. FDA for AVERSA FENTANYL
TIPRANKS  ·  2025-10-28
Nutriband announces meeting completed with U.S. FDA for AVERSA FENTANYL
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
GlobeNewswire  ·  2025-10-28
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
Press Release: Nutriband Co-Founder Gareth Sheridan Returns as CEO
Dow Jones  ·  2025-10-27
Press Release: Nutriband Co-Founder Gareth Sheridan Returns as CEO
Nutriband (NTRB) Receives a Buy from Noble Financial
TIPRANKS  ·  2025-10-23
Nutriband (NTRB) Receives a Buy from Noble Financial
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
THOMSON REUTERS  ·  2025-10-10
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Introduction

Company Name.
Nutriband Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Issue price:
--